Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:52:57.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page. The rest of the trial details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T20:04:54.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No meaningful additions or deletions were detected that affect the study details page; the content remains consistent with the prior version.
    Difference
    0.5%
    Check dated 2025-11-03T14:22:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    3%
    Check dated 2025-10-06T04:31:01.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page now shows revision v3.1.0, replacing v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-29T01:13:33.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' link was deleted.
    Difference
    0.2%
    Check dated 2025-09-14T18:46:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.